The Effect of Acotiamide on Nausea as a Symptom of Chronic Nausea and Vomiting Syndrome after Coronavirus Disease 2019
- PMID: 36543215
- PMCID: PMC10037023
- DOI: 10.2169/internalmedicine.1085-22
The Effect of Acotiamide on Nausea as a Symptom of Chronic Nausea and Vomiting Syndrome after Coronavirus Disease 2019
Abstract
Chronic nausea and vomiting syndrome (CNVS), one of a functional gastroduodenal disorder, was identified in an 8-year-old girl and a 13-year-old boy who had complained of nausea for more than 4 months following coronavirus disease 2019 (COVID-19) due to normality of their head computed tomography and upper gastrointestinal tract images. The patients' symptoms responded quickly to acotiamide, a medication that is effective for treating functional dyspepsia (FD). Despite being a distinct illness from FD, CNVS is also a functional gastrointestinal disorder, and acotiamide may be just as effective for CNVS following COVID-19 as for FD.
Keywords: acotiamide; chronic nausea and vomiting syndrome; coronavirus disease 2019.
Conflict of interest statement
Figures
Similar articles
-
Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.Adv Ther. 2018 Nov;35(11):1884-1893. doi: 10.1007/s12325-018-0814-x. Epub 2018 Oct 22. Adv Ther. 2018. PMID: 30350248
-
Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.Neurogastroenterol Motil. 2016 Jul;28(7):1037-47. doi: 10.1111/nmo.12805. Epub 2016 Feb 27. Neurogastroenterol Motil. 2016. PMID: 26920949 Clinical Trial.
-
A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.J Gastroenterol. 2017 May;52(5):602-610. doi: 10.1007/s00535-016-1260-7. Epub 2016 Sep 17. J Gastroenterol. 2017. PMID: 27639387 Clinical Trial.
-
Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.Expert Opin Investig Drugs. 2011 May;20(5):701-12. doi: 10.1517/13543784.2011.562890. Epub 2011 Mar 22. Expert Opin Investig Drugs. 2011. PMID: 21417958 Review.
-
Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis.ScientificWorldJournal. 2014;2014:541950. doi: 10.1155/2014/541950. Epub 2014 Aug 12. ScientificWorldJournal. 2014. PMID: 25197703 Free PMC article. Review.
References
-
- Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M, Törnblom H. Epidemiology, clinical characteristics, and associations for Rome IV functional nausea and vomiting disorders in adults. Clin Gastroenterol Hepatol 17: 878-886, 2019. - PubMed
-
- Porika SK, Veligandla KC, Muni SK, Acharya S, Mehta SC, Sharma AD. Real-world, non-interventional, observational study to evaluate effectiveness and tolerability of acotiamide hydrochloride hydrate in treatment of functional dyspepsia. Adv Ther 35: 1884-1893, 2018. - PubMed
-
- Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 150: 1257-1261, 2016. - PubMed